Use of Real-World Evidence in EU Clinical Submissions
Use of Real-World Evidence in EU Clinical Submissions Integrating Real-World Evidence into Clinical Submissions in the European Union The role of real-world evidence (RWE) in regulatory submissions has grown significantly in the European Union (EU). While randomized controlled trials (RCTs) remain the gold standard for evaluating efficacy and safety, RWE derived from patient registries, electronic…
Read More “Use of Real-World Evidence in EU Clinical Submissions” »